RSRobert Siida

Robert Siida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Robert Siida has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of antibiotics on the genomic expression of Pseudomonas aeruginosa in the East African community: a systematic review

    by Comfort Danchal Vandu, Ilemobayo Victor Fasogbon, Angela Mumbua Musyoka, Abdulganiy Babatunde Agbaje, Anyanwu Chinyere Njideka, Wusa Makena, Emmanuel O. Ikuomola, Reuben Samson Dangana, Nancy B. Mitaki, Ibe Micheal Usman, et al.

    Introduction Antimicrobial resistance (AMR) is a major global health concern, with the greatest burden observed in lower-middle-income countries. Monitoring AMR through a One Health approach is essential to understand the link between clinical, animal, and environmental sources and to develop targeted interventions. Objectives This systematic review aimed to assess the impact of antibiotics on gene expression in Pseudomonas spp. within the East African Community (EAC). Methodology A thorough literature search across Web of Science, Scopus, and PubMed yielded 284 articles, of which 11 met the inclusion criteria after screening. The selected studies came from five EAC countries. Findings showed a high prevalence of AMR in Pseudomonas aeruginosa , with over 90% resistance to most antibiotics, except Amikacin, which remained effective likely due to limited usage. Results and discussion Common resistance genes identified included carbapenemases such as blaNDM-1 and blaVIM. The disc diffusion method was the most commonly used technique (50%).Multidrug-resistant clones like ST244 and ST357 were frequently reported. Environmental isolates had lower resistance rates (54%) compared to clinical strains (73%), suggesting differing selection pressures. Most studies originated from Kenya and Uganda (each 30%), reflecting differences in research capacity and healthcare infrastructure across the region. Conclusion These results underscore the urgent need for expanded AMR surveillance, stronger antimicrobial stewardship, and further research to inform public health responses in East Africa.


  • Open Access

    Plant-based management of Iron Deficiency Anemia (IDA) in East Africa community: a systematic review

    by Robert Siida, Ilemobayo Victor Fasogbon, Angela Mumbua Musyoka, Basil Uchechukwu Nwali, Sandra Omo Etumah, Idara Asuquo Okon, Ejike Daniel Eze, Afodun Adam, Herbert Mbyemeire, Comfort Danchal Vandu, et al.

    Background Iron Deficiency Anaemia (IDA) is a major public health challenge in East Africa, particularly affecting children and women. Conventional therapies are often limited by accessibility and cost, prompting interest in plant-based interventions as affordable and locally available alternatives. This review explores the potential of medicinal plants in managing IDA, focusing on their phytochemical composition, mechanisms of action, and haematological effects. Methods A systematic search of PubMed, Scopus, and Web of Science databases was conducted on July 17, 2024. The search strategy utilised Boolean operators and keywords related to plants, IDA management, and East Africa. Studies meeting inclusion criteria were peer-reviewed articles published in English that evaluated plant-based treatments for IDA in preclinical or clinical trials. A total of 30 eligible studies were included after screening and quality assessment following PRISMA guidelines. Results The review identified plants such as Moringa oleifera , Phyllanthus emblica , and Telfairia occidentalis as effective in improving haemoglobin levels, red blood cell counts, and other haematological indices. Mechanisms include enhanced iron absorption, antioxidant activity, and stimulation of haematopoiesis. Extraction techniques commonly used were high-performance liquid chromatography (HPLC) and aqueous methods. Key phytochemicals like flavonoids, saponins, and phenolic compounds played critical roles in IDA management. Despite promising outcomes, variations in treatment duration and protocols were noted, highlighting the need for standardisation. Conclusion Plant-based therapies offer accessible, cost-effective solutions for managing IDA in East Africa, leveraging local resources and phytochemical properties. However, further pharmacological and toxicological studies are essential to confirm safety and efficacy. This review emphasises the potential of medicinal plants in addressing IDA and calls for the exploration of underutilised plant species and the development of standardised therapeutic protocols.


  • Open Access

    Preclinical evidence of the efficacy of cucurbita plants in diabetes management: a systematic review

    by Nancy Bonareri Mitaki, Ilemobayo Victor Fasogbon, Augustine Oviosun, Samuel Mong’aRe, Angela Mumbua Musyoka, Vivian Onyinye Ojiakor, Swase Dominic Terkimbi, Peter Chinedu Agu, Wusa Makena, Robert Siida, et al.

    Diabetes mellitus (DM) remains a major global health problem and particularly in low to middle income countries both because of the increasing prevalence and as a result of lack of access to affordable and effective treatment. Given the limitations of current pharmacological treatments, such as side effects and poor compliance, there is increasing interest in natural plant-derived alternatives. This systematic review explores the anti-diabetic potential of Cucurbita species, members of the Cucurbitaceae family, which have demonstrated promising hypoglycemic, antioxidant, and insulinotropic activities in preclinical models. Following PRISMA 2020 criteria, a comprehensive search of PubMed, Scopus, and Web of Science identified 16 eligible preclinical studies published between 2016 and 2025 that met strict inclusion criteria. Extracts from Cucurbita maxima, C. moschata, C. ficifolia, and C. pepo were shown to significantly reduce blood glucose concentrations, enhance antioxidant enzyme activity, promote pancreatic β-cell regeneration, and improve lipid profiles in diabetic animal models. These effects were predominantly observed following oral administration, reflecting traditional usage patterns and supporting clinical translatability. The geographically diverse research landscape underscores the global ethnobotanical relevance of Cucurbita species as complementary or alternative treatments for DM. However, the review also highlights gaps in the research, including the need for further pharmacokinetic, toxicological, and clinical studies to validate the efficacy and safety of these botanicals and to inform the development of standardized phytotherapeutic interventions. Overall, Cucurbita plants present a compelling case for further investigation as adjunct or alternative treatments for diabetes mellitus.